Shanghai Pharmaceuticals, one of China’s biggest drug manufacturers and distributors, is to raise up to $2.2bn through an offering of new shares in Hong Kong, according to people close to the transaction.
知情人士稱，中國最大制藥商和藥物分銷商之一上海醫藥(Shanghai Pharmaceuticals)，將通過在香港發行新股籌資至多22億美元。
您已閱讀8%（276字），剩余92%（3150字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。